Curacity
PrivateLast Round
Series A
Aug 10, 2021
Total Funding Raised
$8.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Curacity operates in Enterprise Software and is based in New York City, New York. Its latest recorded funding round was a Series A round in August 2021.
Curacity is a hospitality technology company that provides a demand creation platform to help travel brands measure revenue and bookings from upper-funnel marketing content.
Sector
Enterprise Software
Verticals
Marketing, Influencer Marketing, Digital Publishing, Business Intelligence, Content Creation
Business Model
B2B
Customer Profile
Usage-Based SaaS, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curacity Comparables
Compare Curacity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nooon | 77% | |
| Triptease | 70% | |
| RateGain Travel Technologies | 69% |
For institutional investors. Book with your work email.
Curacity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 10, 2021 | ||||
| Series A | Jan 25, 2020 | ||||
| Seed | Feb 22, 2018 | ||||
| Seed | Oct 15, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Curacity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Seed |
| Entrepreneurs Roundtable Accelerator | Series A, Seed |
| Third Prime | Series A |
| Revel Partners | Series A, Seed |
| SoftBank Capital | Series A |
| SoftBank Group | Series A |
| Greycroft | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 54% MoM, from 3.7K to 5.6K.
- May 17, 2026
Grew 20% QoQ from 51 to 61 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 10, 2026
Curacity and Bonafide announce a strategic partnership in New York on Sep 10th '26 that connects recommendation intelligence, demand generation and verified brand context to help hospitality brands improve discovery, recommendations and direct bookings across the AI-led travel journey.
For institutional investors. Book with your work email.
Curacity Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curacity's valuation, stock price, and market status.
Is Curacity a public or private company?
Curacity is a private company.
What is the current stock price of Curacity?
Curacity is a private company, so its shares have no public market price. Caplight tracks Curacity's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curacity worth (valuation)?
Valuation information for Curacity is not publicly available.
Can I buy Curacity stock?
Curacity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curacity's last funding round?
Curacity's most recent funding round was Series A on August 10, 2021.
Who are the main investors in Curacity?
Key investors in Curacity include Entrepreneurs Roundtable Accelerator, Third Prime, Revel Partners, SoftBank Group, Correlation Ventures.
Will Curacity IPO soon?
No public IPO plans have been announced for Curacity.
How can I track Curacity secondary market activity?
Caplight tracks bids, offers, and trades in Curacity's shares on secondary markets.